Yahoo
    OTC Markets OTCPK - Delayed Quote USD

    Sernova Biotherapeutics Inc (SEOVF)

    0.0800 0.0000 (0.00%)
    At close: October 30 at 4:00:00 PM EDT
    Loading Chart for SEOVF
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    View More
    Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics

    Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics
    GlobeNewswire 12d ago
    Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial

    Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial
    GlobeNewswire 26d ago
    Sernova Biotherapeutics to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference

    Sernova Biotherapeutics to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference
    GlobeNewswire 1mo ago

    Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc.
    TMX Newsfile 1mo ago
    Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference

    Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference
    GlobeNewswire 1mo ago
    Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

    Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics
    GlobeNewswire 1mo ago
    A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up

    A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up
    CNW Group 3mo ago
    Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy

    Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
    GlobeNewswire 4mo ago
    Sernova Biotherapeutics Announces Closing of Recently Approved Financings

    Sernova Biotherapeutics Announces Closing of Recently Approved Financings
    TMX Newsfile 6mo ago
    Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders

    Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders
    TMX Newsfile 6mo ago
    Cell Encapsulation Global Market Report 2026-2035 | Features Strategic Profiles of Beta-Cell, Betalin Therapeutics, Beta-O2 Technologies, Diatranz Otsuka, Neurotech, Semma Therapeutics, Sernova, ViaCyte

    Cell Encapsulation Global Market Report 2026-2035 | Features Strategic Profiles of Beta-Cell, Betalin Therapeutics, Beta-O2 Technologies, Diatranz Otsuka, Neurotech, Semma Therapeutics, Sernova, ViaCyte
    GlobeNewswire 2mo ago
    View More

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: